Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorke

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Toxicology|December 26, 2022
The effects of hexabromocyclododecane on the transcriptome and hepatic enzyme activity in three human HepaRG-based modelsSusana Proença, Nick van Sabben, Juliette Legler, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|June 17, 2021
Developmental exposure to a POPs mixture or PFOS increased body weight and reduced swimming ability but had no effect on reproduction or behavior in zebrafish adultsMaria Christou, Erik Ropstad, Stephen Brown, et al.
Best Practice & Research. Clinical Gastroenterology|June 19, 2017
From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrixJorke Willemse, Ruby Lieshout, Luc J W van der Laan, et al.
Journal of Hazardous Materials|November 17, 2020
High-throughput analyses and Bayesian network modeling highlight novel epigenetic Adverse Outcome Pathway networks of DNA methyltransferase inhibitor mediated transgenerational effectsYou Song, Jorke H Kamstra, Yang Cao, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1985
Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosisA Traeger, R Häntze, M Penzlin, et al.
Methodsx|November 11, 2017
Optimization of an <i>in vitro</i> assay methodology for competitive binding of thyroidogenic xenobiotics with thyroxine on human transthyretin and albuminKatie L Hill, Timo Hamers, Jorke H Kamstra, et al.
Toxicology Letters|January 7, 2018
Organophosphate triesters and selected metabolites enhance binding of thyroxine to human transthyretin in vitroKatie L Hill, Timo Hamers, Jorke H Kamstra, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1985
[Emergency endoscopy in chronic liver diseases]J Truckenbrodt, H Bosseckert, D Jorke, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 28, 1991
Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseasesA Müller, B Krombholz, G Pott, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
[Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study]M Reinhardt, D Jorke, G Jahn, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Toxicology|December 26, 2022
The effects of hexabromocyclododecane on the transcriptome and hepatic enzyme activity in three human HepaRG-based modelsSusana Proença, Nick van Sabben, Juliette Legler, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|June 17, 2021
Developmental exposure to a POPs mixture or PFOS increased body weight and reduced swimming ability but had no effect on reproduction or behavior in zebrafish adultsMaria Christou, Erik Ropstad, Stephen Brown, et al.
Best Practice & Research. Clinical Gastroenterology|June 19, 2017
From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrixJorke Willemse, Ruby Lieshout, Luc J W van der Laan, et al.
Journal of Hazardous Materials|November 17, 2020
High-throughput analyses and Bayesian network modeling highlight novel epigenetic Adverse Outcome Pathway networks of DNA methyltransferase inhibitor mediated transgenerational effectsYou Song, Jorke H Kamstra, Yang Cao, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1985
Pharmacokinetics and pharmacodynamic effects of furosemide in patients with liver cirrhosisA Traeger, R Häntze, M Penzlin, et al.
Methodsx|November 11, 2017
Optimization of an <i>in vitro</i> assay methodology for competitive binding of thyroidogenic xenobiotics with thyroxine on human transthyretin and albuminKatie L Hill, Timo Hamers, Jorke H Kamstra, et al.
Toxicology Letters|January 7, 2018
Organophosphate triesters and selected metabolites enhance binding of thyroxine to human transthyretin in vitroKatie L Hill, Timo Hamers, Jorke H Kamstra, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1985
[Emergency endoscopy in chronic liver diseases]J Truckenbrodt, H Bosseckert, D Jorke, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 28, 1991
Collagen peptidase and type III procollagen peptide serum levels in chronic liver diseasesA Müller, B Krombholz, G Pott, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1986
[Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study]M Reinhardt, D Jorke, G Jahn, et al.
Pageof 11